mirror of
https://github.com/msberends/AMR.git
synced 2026-11-16 06:30:48 +01:00
Include isolates of unknown species in grouped antibiograms and in wisca(), which were silently excluded with the warning 'invalid microorganism code, NA generated'
This commit is contained in:
1 parent
3a87075ad3
commit
eb6d07e1fe
4 files changed
+28
-7
No files matched your search
@@ -220,12 +220,11 @@ the full explanation.
|
||||
wisca(example_isolates,
|
||||
antimicrobials = c("TZP", "TZP+TOB", "TZP+GEN"),
|
||||
minimum = 10) # Recommended threshold: >=30
|
||||
#> Warning: invalid microorganism code, NA generated
|
||||
```
|
||||
|
||||
| Piperacillin/tazobactam | Piperacillin/tazobactam + Gentamicin | Piperacillin/tazobactam + Tobramycin |
|
||||
|:------------------------|:-------------------------------------|:-------------------------------------|
|
||||
| 69.8% (64.5-74.7%) | 93.6% (92.1-95%) | 89.9% (87-92.5%) |
|
||||
| 70.2% (65-75.4%) | 93.6% (92-95.1%) | 89.9% (87-92.5%) |
|
||||
|
||||
WISCA supports stratification by any clinical variable, so you can
|
||||
generate syndrome-specific or ward-specific coverage estimates:
|
||||
@@ -235,14 +234,13 @@ wisca(example_isolates,
|
||||
antimicrobials = c("TZP", "TZP+TOB", "TZP+GEN"),
|
||||
syndromic_group = "ward",
|
||||
minimum = 10) # Recommended threshold: >=30
|
||||
#> Warning: invalid microorganism code, NA generated
|
||||
```
|
||||
|
||||
| Syndromic Group | Piperacillin/tazobactam | Piperacillin/tazobactam + Gentamicin | Piperacillin/tazobactam + Tobramycin |
|
||||
|:----------------|:------------------------|:-------------------------------------|:-------------------------------------|
|
||||
| Clinical | 74.6% (69.1-80.1%) | 93.7% (92.1-95.1%) | 90.3% (87-93.1%) |
|
||||
| ICU | 56.9% (48.3-66%) | 86.7% (83.5-89.8%) | 83% (77.9-87.4%) |
|
||||
| Outpatient | 57.7% (46.5-69.3%) | 76.6% (70.5-82.2%) | 67.8% (56.9-77.5%) |
|
||||
| Clinical | 74.8% (69-80.3%) | 93.7% (92.1-95.1%) | 90.4% (86.8-93.3%) |
|
||||
| ICU | 56.7% (48.2-65.4%) | 86.6% (83.3-89.6%) | 83.1% (78.2-87.5%) |
|
||||
| Outpatient | 57.6% (46-69%) | 76.4% (69.8-81.7%) | 68% (57.7-77.5%) |
|
||||
|
||||
**For AMR surveillance**, traditional antibiograms remain the right tool
|
||||
for tracking resistance per species over time:
|
||||
|
||||
Reference in new issue
Block a user